Leading Health Technologies Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
as on 08-12-2024
- Paid Up Capital ₹ 3.50 M
as on 08-12-2024
- Company Age 22 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.15 Cr
as on 08-12-2024
- Satisfied Charges ₹ 1.00 Cr
as on 08-12-2024
- Revenue -11.08%
(FY 2020)
- Profit -55.45%
(FY 2020)
- Ebitda 594.90%
(FY 2020)
- Net Worth 2.17%
(FY 2020)
- Total Assets -18.50%
(FY 2020)
About Leading Health Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹3.15 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Seema Gulyani, Rajiv Gulyani, and Neelam Gulyani serve as directors at the Company.
- CIN/LLPIN
U51397DL2002PTC114516
- Company No.
114516
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Leading Health Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Gulyani  | Director | 08-Mar-2002 | Current |
| Seema Gulyani | Director | 08-Mar-2002 | Current |
| Neelam Gulyani | Director | 08-Mar-2002 | Current |
Financial Performance of Leading Health Technologies.
Leading Health Technologies Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 11.08% decrease. The company also saw a substantial fall in profitability, with a 55.45% decrease in profit. The company's net worth moved up by a moderate rise of 2.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Leading Health Technologies?
In 2019, Leading Health Technologies had a promoter holding of 35.43% and a public holding of 64.58%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Nov 2022 | ₹3.15 Cr | Open |
Others Creation Date: 10 Apr 2016 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Leading Health Technologies?
Unlock and access historical data on people associated with Leading Health Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leading Health Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leading Health Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
